Results 21 to 30 of about 747,509 (280)

Procedure for Identifying Nonsense Mutations [PDF]

open access: yesJournal of Bacteriology, 1968
A method has been devised for the rapid identification of nonsense mutations (UAG, UAA, UGA codons) in Salmonella . The mutations to be tested are reverted, and the revertants are replica-printed onto lactose plates spread with lawns of tester strains.
D, Berkowitz   +4 more
openaire   +2 more sources

Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood [PDF]

open access: yes, 2005
BACKGROUND: Pulmonary arterial hypertension (PAH) is a potentially fatal vasculopathy that can develop at any age. Adult-onset disease has previously been associated with mutations in BMPR2 and ALK-1.
Haworth, SG   +22 more
core   +1 more source

dnaB125, a dnaB nonsense mutation [PDF]

open access: yesJournal of Bacteriology, 1981
A temperature-sensitive dnaB mutation, dnaB125, was shown to be a suppressed amber mutation. The effects of inserting different amino acids at the mutated site via amber suppressors were examined for both Escherichia coli and bacteriophage gamma growth.
R A, Sclafani, J A, Wechsler
openaire   +2 more sources

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

open access: yesNature Communications, 2020
Nonsense mutations can be corrected by several molecules that activate readthrough of premature termination codon. Here, the authors report that 2,6-diaminopurine efficiently corrects UGA nonsense mutations with no significant toxicity.
Carole Trzaska   +21 more
doaj   +1 more source

Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells. [PDF]

open access: yesPLoS ONE, 2011
The APC tumor suppressor gene is frequently mutated in human colorectal cancer, with nonsense mutations accounting for 30% of all mutations in this gene.
Célia Floquet   +2 more
doaj   +1 more source

Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing

open access: yesMolecular Therapy: Methods & Clinical Development, 2020
Nonsense-mediated decay (NMD) is a major pathogenic mechanism underlying a diversity of genetic disorders. Nonsense variants tend to lead to more severe disease phenotypes and are often difficult targets for small molecule therapeutic development as a ...
Steven Erwood   +6 more
doaj   +1 more source

Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC

open access: yesHereditary Cancer in Clinical Practice, 2021
Background and purposes The pathogenic BRCA1/2 germline mutations contributed to Hereditary Breast and Ovarian Cancer (HBOC) susceptibility. The features of BRCA1/2 germline mutations in non-small cell lung cancer (NSCLC) have not been systematically ...
Zheyuan Xu   +6 more
doaj   +1 more source

Suppression of dnaE nonsense mutations by pcbA1 [PDF]

open access: yesJournal of Bacteriology, 1989
DNA polymerase III has been recognized as the required replication enzyme in Escherichia coli. The synthesis subunit of DNA polymerase III holoenzyme (alpha subunit) is encoded by the dnaE gene. We have reported that E. coli cells can survive and grow in the absence of a functional dnaE gene product if DNA polymerase I and the pcbA1 mutation are ...
H, Maki   +3 more
openaire   +2 more sources

Friedreich’s Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases

open access: yesCase Reports in Neurological Medicine, 2018
Friedreich’s ataxia is a neurodegenerative disorder associated with a GAA trinucleotide repeat expansion in intron 1 of the frataxin (FXN) gene. It is the most common autosomal recessive cerebellar ataxia, with a mean age of onset at 16 years.
Vamshi K. Rao   +2 more
doaj   +1 more source

Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.

open access: yesPLoS ONE, 2023
A major unmet need in the cystic fibrosis (CF) therapeutic landscape is the lack of effective treatments for nonsense CFTR mutations, which affect approximately 10% of CF patients.
Chao Li   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy